Rachel Hodan

489 total citations · 1 hit paper
16 papers, 104 citations indexed

About

Rachel Hodan is a scholar working on Genetics, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Rachel Hodan has authored 16 papers receiving a total of 104 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 5 papers in Pathology and Forensic Medicine and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Rachel Hodan's work include BRCA gene mutations in cancer (12 papers), Genomics and Rare Diseases (6 papers) and Genetic factors in colorectal cancer (5 papers). Rachel Hodan is often cited by papers focused on BRCA gene mutations in cancer (12 papers), Genomics and Rare Diseases (6 papers) and Genetic factors in colorectal cancer (5 papers). Rachel Hodan collaborates with scholars based in United States, Norway and Switzerland. Rachel Hodan's co-authors include Allison W. Kurian, Paul Abrahamse, Kevin C. Ward, Jonathan S. Berek, Steven J. Katz, Thomas P. Slavin, Amal Yussuf, Ann S. Hamilton, Scarlett Lin Gomez and Lisa R. Susswein and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and BMC Cancer.

In The Last Decade

Rachel Hodan

15 papers receiving 104 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Germline Genetic Testing After Cancer Diagnosis

2023 66 citations Allison W. Kurian, Paul Abrahamse et al. JAMA profile →

Peers

Countries citing papers authored by Rachel Hodan

Since Specialization

Citations

This map shows the geographic impact of Rachel Hodan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Hodan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Hodan more than expected).

Fields of papers citing papers by Rachel Hodan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Hodan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Hodan. The network helps show where Rachel Hodan may publish in the future.

Co-authorship network of co-authors of Rachel Hodan

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Hodan. A scholar is included among the top collaborators of Rachel Hodan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Hodan. Rachel Hodan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	The Genetic Information and Family Testing (GIFT) study: trial design and protocol 2025 ·BMC Cancer ·(unknown), Paul Abrahamse, Timothy P. Hofer, (unknown), Rachel Hodan, Rachel Tocco, (unknown), Kevin R. Ward, Ann S. Hamilton, Allison W. Kurian, Lawrence C. An	0
2	Breast Cancer MRI Screening of Patients After Multiplex Gene Panel Testing 2025 ·JAMA Network Open ·(unknown), Julie O. Culver, Charité Ricker, (unknown), Kerry Kingham, Rachel Hodan, Nicolette M. Chun, John Kidd, Joseph D. Bonner, Christine Hong, (unknown), (unknown), (unknown), Kevin McDonnell, Uri Ladabaum, James M. Ford, Stephen B. Gruber, Allison W. Kurian, Gregory Idos	1
3	Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer 2024 ·Journal of Clinical Oncology ·Steven J. Katz, Paul Abrahamse, Allison Furgal, Rachel Hodan, Rachel Tocco, Kevin C. Ward, Ann S. Hamilton, Lauren P. Wallner, Allison W. Kurian	2
4	Family health beliefs and cascade genetic testing in Asian families with hereditary cancer risk: “Okay, now what?” 2024 ·Journal of Genetic Counseling ·(unknown), Jennifer L. Young, Claire Barton, Rachel Hodan, Andrea Hanson‐Kahn, (unknown)	1
5	Family communication of cancer genetic test results in an ethnically diverse population: a qualitative exploration of more than 200 patients 2024 ·Journal of Community Genetics ·Rachel Hodan, (unknown), (unknown), Kelly E. Ormond, (unknown), Allison W. Kurian, Charité Ricker, Gregory Idos	1
6	Attitudes and engagement about cascade genetic testing among women diagnosed with cancer. 2024 ·JCO Oncology Practice ·(unknown), Lauren P. Wallner, Sarah T. Hawley, Paul Abrahamse, Rachel Hodan, Allison W. Kurian	1
7	Clinical implications of conflicting variant interpretations in the cancer genetics clinic 2023 ·Genetics in Medicine ·(unknown), Julie O. Culver, Yuxi Liu, (unknown), Charité Ricker, Rachel Hodan, (unknown), Kerry Kingham, Nicolette M. Chun, (unknown), Kathryn Singh, Jason A. Zell, Uri Ladabaum, Kevin McDonnell, James M. Ford, Giovanni Parmigiani, Danielle Braun, Allison W. Kurian, Stephen B. Gruber, Gregory Idos	3
8	Cascade Genetic Risk Education and Testing in Families With Hereditary Cancer Syndromes: A Pilot Study 2023 ·JCO Oncology Practice ·Steven J. Katz, Paul Abrahamse, Rachel Hodan, Allison W. Kurian, (unknown), Rachel Tocco, (unknown), Kevin C. Ward, Lawrence C. An	2
9	Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey 2023 ·Frontiers in Oncology ·(unknown), Rachel Hodan, Linda Rodgers, Sanjeevani Arora, Francesc Balaguer, José G. Guillem, Joanne Jeter, Priyanka Kanth, Dan Li, David Liska, Joshua Melson, Kimberly Perez, Charité Ricker, Brian H. Shirts, Eduardo Vilar, Bryson W. Katona, Mev Dominguez–Valentin	6
10	Cancer surveillance for transgender and gender diverse patients with Lynch syndrome: a practice resource of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer 2023 ·Familial Cancer ·Rachel Hodan, Linda Rodgers, Anu Chittenden, Mev Dominguez–Valentin, J. Stuart Ferriss, (unknown), Ole‐Petter R. Hamnvik, Gregory Idos, (unknown), (unknown), Jessica M. Long, Danielle McKenna, Charles Muller, (unknown), Anton Wintner, Bronwyn S. Bedrick, (unknown)	3
11	Genetic testing into survivorship after diagnosis of breast cancer. 2023 ·Journal of Clinical Oncology ·Steven J. Katz, Rachel Hodan, Paul Abrahamse, Rachel Tocco, Timothy P. Hofer, Lauren P. Wallner, Allison W. Kurian	1
12	Germline Genetic Testing After Cancer Diagnosis breakdown → 2023 ·JAMA ·Allison W. Kurian, Paul Abrahamse, Allison Furgal, Kevin C. Ward, Ann S. Hamilton, Rachel Hodan, Rachel Tocco, Lihua Liu, Jonathan S. Berek, Lily Hoang, Amal Yussuf, Lisa R. Susswein, Edward D. Esplin, Thomas P. Slavin, Scarlett Lin Gomez, Timothy P. Hofer, Steven J. Katz	66
13	Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice Survey 2023 ·JCO Precision Oncology ·Linda Rodgers, Sanjeevani Arora, Charité Ricker, Dan Li, Maheen Farooqi, Francesc Balaguer, Mev Dominguez–Valentin, José G. Guillem, Priyanka Kanth, David Liska, Joshua Melson, (unknown), Brian H. Shirts, Eduardo Vilar, Bryson W. Katona, Rachel Hodan	2
14	Patterns of germline and somatic testing after universal tumor screening for Lynch syndrome: A clinical practice survey of active members of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer 2022 ·Journal of Genetic Counseling ·Rachel Hodan, Linda Rodgers, Sanjeevani Arora, Mev Dominguez–Valentin, Priyanka Kanth, Bryson W. Katona, (unknown), Maegan E. Roberts, Eduardo Vilar, (unknown), Randall E. Brand, Edward D. Esplin, Kimberly Perez	3
15	Hereditary inflammatory fibroid polyps caused by germline pathogenic variants in PDGFRA: Refining PDGFRA-mutation syndrome 2021 ·Cancer Genetics ·Rachel Hodan, Gregory W. Charville, Uri Ladabaum	4
16	Prevalence of Lynch syndrome in women with mismatch repair‐deficient ovarian cancer 2020 ·Cancer Medicine ·Rachel Hodan, Kerry Kingham, Kristina Cotter, Ann K. Folkins, Allison W. Kurian, James M. Ford, Teri A. Longacre	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact